Boston Scientific, Guidant Push Back Closing Date, Warn Of Merger Risks
This article was originally published in The Gray Sheet
Executive Summary
A one-week delay in the $27.2 mil. merger of Boston Scientific and Guidant will cause Boston Scientific to ante up penalty fees to Guidant shareholders